Haloperidol binding to an opiate receptor site.
D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006220:Haloperidol / Q000378:metabolism* / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D009020:Morphine / Q000378:metabolism / Q000494:pharmacology; D009270:Naloxone / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug; D012964:Sodium / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014316:Tritium
D011955:Receptors, Drug; D014316:Tritium; D009270:Naloxone; D009020:Morphine; D012964:Sodium; D006220:Haloperidol